Pharmacokinetics and Safety of M107 Orally Disintegrating Tablet in Healthy Adults

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of lobeglitazone administered as M107 Orally Disintegrating Tablet and Duvie tablet in healthy adult participants under fasted and fed conditions.
Epistemonikos ID: 86f5eadd95ae804baafefd95d7a21c1ddc3e2e0c
First added on: Jul 10, 2025